Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency

成像和放射治疗的进展有可能引发癌症的广泛改善 诊断和治疗。然而，放射肿瘤学和放射学取得进展的一个主要障碍是 缺乏受过必要培训以做出变革性发现的内科科学家。因此， 迫切需要开发新的途径，以扩大指导研究，以保持更多的辐射 研究中的肿瘤学家和放射科医生。为了解决这一差距，我们提出了杜克放射肿瘤学和 促进住院研究机会的放射学(Duke Ror Starr)计划，其中心 通过保护时间培养放射肿瘤学和放射学住院调查人员的使命 进行有指导的研究，从而造就一支将做出未来发现的内科科学家队伍 这将促进癌症的成像和治疗。具有跨越临床和基础的多部门战略 科学系、常驻调查员将体验个性化、多面性和连续性 培训，嵌入一个强有力的机构框架，为内科科学家提供支持。一个由多人组成的团队 纪律严明、资金雄厚的教员P受体，以及一群才华横溢的新兴P受体，提供研究 沿着癌症研究连续体的领域的机会，从基础辐射和癌症生物学到前 临床影像和转化性研究，到早期临床试验。这些领域针对的是NCI战略 研究重点包括剖析癌症的病理生物学机制和开发新的 诊断和治疗策略。该计划将包括五个培训目标：(1)全面 关于专业发展和基础、翻译和临床研究的教学；(2)研究项目 和个人职业发展计划；(3)学术活动；(4)美国董事会资格 放射学；以及(5)实习后继续指导临床分科研究的途径 发展。由Pi David Kirsch(放射肿瘤学)领导，副项目主任Joseph Lo (放射学)和Scott Floyd(放射肿瘤学)，以及部门派驻计划主任， 该计划将支持放射肿瘤学、诊断放射学和/或 每年的介入放射学，谁将完成12-24个月的指导研究。体制性 支持包括医生科学家发展办公室的资源，部门工资支持， 由医学院资助的研究补充材料，并优先考虑获得专科奖学金或 由杜克癌症研究所支持的杜克大学研究密集型讲师职位将确保在 完成这项计划后，这些人将成为下一代领导 放射肿瘤学和放射学研究。实现该计划的目标将满足以下方面的迫切需求： 1)在放射肿瘤学和放射学方面有更多的内科-科学家，2)在成像、癌症方面的创新 生物学和放射肿瘤学，以改变癌症患者的生活。

Advances in imaging and radiation therapy have the potential to spark widespread improvements in cancer diagnosis and treatment. However, a major barrier to progress in Radiation Oncology and Radiology is a shortage of physician-scientists with the necessary training to make transformative discoveries. Therefore, there is an urgent need to develop novel pathways for extended mentored research to retain more radiation oncologists and radiologists in research. To address this gap, we propose a Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency (Duke ROR StARR) Program, with its central mission to cultivate Resident-Investigators in Radiation Oncology and Radiology through protected time to perform mentored research, therefore creating a cadre of physician-scientists who will make future discoveries that advance imaging and treatment of cancer. With a multi-departmental strategy spanning clinical and basic science departments, Resident-Investigators will experience individualized, multifaceted, and continuous training, embedded within a robust, institutional framework for physician scientist support. A team of multi- disciplinary, well-funded faculty Preceptors, as well as a group of talented Rising Preceptors, offer research opportunities in areas along the cancer research continuum from basic radiation and cancer biology, to pre- clinical imaging and translational studies, to early phase clinical trials. These areas address NCI strategic research priorities that include dissecting pathobiological mechanisms of cancer and developing novel diagnostic and therapeutic strategies. The program will consist of five training Aims: (1) Comprehensive didactics on professional development and basic, translational, and clinical research; (2) A research project and individual career development plan; (3) Scholarly activity; (4) Board eligibility for the American Board of Radiology; and (5) A path for continued post-residency mentored research training with sub-specialty clinical development. Led by PI David Kirsch (Radiation Oncology), Associate Program Directors Joseph Lo (Radiology) and Scott Floyd (Radiation Oncology), and departmental Residency Program Directors, the program will support three Resident-Investigators in Radiation Oncology, Diagnostic Radiology and/or Interventional Radiology per year, who will complete 12-24 months of mentored research. Institutional support including resources from the Office of Physician Scientist Development, departmental salary support, a research supplement funded by the School of Medicine, and preferences for a subspecialty fellowship or research-intensive Instructor position at Duke supported by the Duke Cancer Institute will ensure that after completing the program, these individuals will be poised to become the next generation of physicians to lead research in Radiation Oncology and Radiology. Achieving the Program's objectives will fulfill urgent needs for: 1) more physician-scientists in Radiation Oncology and Radiology and 2) innovations in imaging, cancer biology, and radiation oncology to transform the lives of cancer patients.